Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2329 - 2336 of 11456 results
Patent Owner Tip #17 for Surviving an Instituted IPR: Alternatives to Motions to Amend in IPR Proceedings
September 2, 2021| Blog| Viewpoint
FBI Warning: Ransomware Attackers Don’t Take Holidays
September 2, 2021| Blog| Viewpoint
What’s New in 5G - September 2021
September 1, 2021| Blog| Viewpoint
Life Sciences Newsletter — September 2021
September 1, 2021| Article| Viewpoint
Immigration Lawyers Reveal 8 Secret Behind Their Strategies to Win Visas for Startup Workers
September 1, 2021| News
Nonobviousness of Commercially Successful Designs: Mmm, Mmm, Not So Fast
August 31, 2021| Blog| Viewpoint
Over 55 of the Nation’s Leading Law Firms Respond to Investment Company Act Lawsuits Targeting the SPAC Industry
August 30, 2021| Blog| Viewpoint
White Collar Vet Departs Schulte Roth for Mintz in New York
August 27, 2021| News
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.